Pages that link to "Q30999041"

The following pages link to High T-cell immune activation and immune exhaustion among individuals with suboptimal CD4 recovery after 4 years of antiretroviral therapy in an African cohort (Q30999041):

Displaying 50 items.

• Role of PD-1 in HIV pathogenesis and as target for therapy (Q24634293) ‎ (← links)
• HIV-1 functional cure: will the dream come true? (Q26865803) ‎ (← links)
• Incomplete immune recovery in HIV infection: mechanisms, relevance for clinical care, and possible solutions (Q27021524) ‎ (← links)
• Re-evaluation of PD-1 expression by T cells as a marker for immune exhaustion during SIV infection (Q27331338) ‎ (← links)
• Mechanistic insights on immunosenescence and chronic immune activation in HIV-tuberculosis co-infection (Q28081838) ‎ (← links)
• Low Incidence of HIV-1C Acquired Drug Resistance 10 Years after Roll-Out of Antiretroviral Therapy in Ethiopia: A Prospective Cohort Study (Q28550552) ‎ (← links)
• Cycling memory CD4+ T cells in HIV disease have a diverse T cell receptor repertoire and a phenotype consistent with bystander activation. (Q33602906) ‎ (← links)
• Tobacco smoking increases immune activation and impairs T-cell function in HIV infected patients on antiretrovirals: a cross-sectional pilot study (Q33632786) ‎ (← links)
• Galectin-9 is rapidly released during acute HIV-1 infection and remains sustained at high levels despite viral suppression even in elite controllers (Q33828349) ‎ (← links)
• Clinical predictors of immune reconstitution following combination antiretroviral therapy in patients from the Australian HIV Observational Database (Q33933071) ‎ (← links)
• Cytokine/Chemokine responses in activated CD4+ and CD8+ T cells isolated from peripheral blood, bone marrow, and axillary lymph nodes during acute simian immunodeficiency virus infection (Q34059178) ‎ (← links)
• Attenuation of immune activation in an open-label clinical trial for HIV-AIDS using a polyherbal formulation (Q34300102) ‎ (← links)
• Human endogenous retrovirus expression is inversely associated with chronic immune activation in HIV-1 infection (Q34373981) ‎ (← links)
• Programmed death-1 expression on CD4⁺ and CD8⁺ T cells in treated and untreated HIV disease (Q34388154) ‎ (← links)
• T cell activation markers and African mitochondrial DNA haplogroups among non-Hispanic black participants in AIDS clinical trials group study 384. (Q34411977) ‎ (← links)
• Cytokine network in adults with falciparum Malaria and HIV-1: increased IL-8 and IP-10 levels are associated with disease severity (Q34682109) ‎ (← links)
• Impaired T-cell proliferation among HAART-treated adults with suboptimal CD4 recovery in an African cohort (Q34779237) ‎ (← links)
• Immune response to Leishmania antigens in an AIDS patient with mucocutaneous leishmaniasis as a manifestation of immune reconstitution inflammatory syndrome (IRIS): a case report (Q35553902) ‎ (← links)
• Atorvastatin reduces T-cell activation and exhaustion among HIV-infected cART-treated suboptimal immune responders in Uganda: a randomised crossover placebo-controlled trial (Q35929446) ‎ (← links)
• Interleukin-37 Expression Is Increased in Chronic HIV-1-Infected Individuals and Is Associated with Inflammation and the Size of the Total Viral Reservoir (Q35946786) ‎ (← links)
• Low antigen-specific CD4 T-cell immune responses despite normal absolute CD4 counts after long-term antiretroviral therapy an African cohort (Q35956923) ‎ (← links)
• Virologic and immunologic effects of adding maraviroc to suppressive antiretroviral therapy in individuals with suboptimal CD4+ T-cell recovery (Q36263361) ‎ (← links)
• Immune activation and HIV-specific T cell responses are modulated by a cyclooxygenase-2 inhibitor in untreated HIV-infected individuals: An exploratory clinical trial (Q36360872) ‎ (← links)
• Effective Cytotoxic T Lymphocyte Targeting of Persistent HIV-1 during Antiretroviral Therapy Requires Priming of Naive CD8+ T Cells (Q36974205) ‎ (← links)
• CD4 T-cell activation and reduced regulatory T-cell populations are associated with early development of cataracts among HIV-infected adults in Uganda (Q37002936) ‎ (← links)
• High-risk oncogenic HPV genotype infection associates with increased immune activation and T cell exhaustion in ART-suppressed HIV-1-infected women (Q37012660) ‎ (← links)
• Dynamics of cytokine/chemokine responses in intestinal CD4+ and CD8+ T Cells during Acute Simian Immunodeficiency Virus Infection (Q37252772) ‎ (← links)
• Poor immunological recovery among severely immunosuppressed antiretroviral therapy-naïve Ugandans (Q37378374) ‎ (← links)
• Low Double-Negative CD3+CD4-CD8- T Cells Are Associated with Incomplete Restoration of CD4+ T Cells and Higher Immune Activation in HIV-1 Immunological Non-Responders (Q37486642) ‎ (← links)
• Virological efficacy and immunological recovery among Ethiopian HIV-1 infected adults and children (Q37509894) ‎ (← links)
• High CD56++CD16- natural killer (NK) cells among suboptimal immune responders after four years of suppressive antiretroviral therapy in an African adult HIV treatment cohort (Q37558647) ‎ (← links)
• Immunodiscordant responses to HAART--mechanisms and consequences (Q38156230) ‎ (← links)
• Clinical Trial of the Anti-PD-L1 Antibody BMS-936559 in HIV-1 Infected Participants on Suppressive Antiretroviral Therapy (Q38826536) ‎ (← links)
• Unrecognised tuberculosis at antiretroviral therapy initiation is associated with lower CD4+ T cell recovery (Q38866845) ‎ (← links)
• The role of SNPs in the α-chain of the IL-7R gene in CD4+ T-cell recovery in HIV-infected African patients receiving suppressive cART. (Q38869327) ‎ (← links)
• Association between discordant immunological response to highly active anti-retroviral therapy, regulatory T cell percentage, immune cell activation and very low-level viraemia in HIV-infected patients. (Q39422439) ‎ (← links)
• T cell anergy and activation are associated with suboptimal humoral responses to measles revaccination in HIV-infected children on anti-retroviral therapy in Nairobi, Kenya. (Q41295794) ‎ (← links)
• Tripterygium wilfordii Hook F extract in cART-treated HIV patients with poor immune response: a pilot study to assess its immunomodulatory effects and safety (Q41333604) ‎ (← links)
• Preserved immune functionality and high CMV-specific T-cell responses in HIV-infected individuals with poor CD4+ T-cell immune recovery (Q41718407) ‎ (← links)
• HIV/Human herpesvirus co-infections: Impact on tryptophan-kynurenine pathway and immune reconstitution (Q41920878) ‎ (← links)
• Fuzhengpaidu granule regulates immune activation molecules CD38 and human leukocyte antigen-D related on CD4+ and CD8+ T cells in patients with acquired immunodeficiency syndrome/human immunodeficiency virus (Q42257961) ‎ (← links)
• HIV as a Cause of Immune Activation and Immunosenescence (Q47151081) ‎ (← links)
• Impact of Human Immunodeficiency Virus Infection on Survival and Acute Toxicities From Chemoradiation Therapy for Cervical Cancer Patients in a Limited-Resource Setting. (Q52605454) ‎ (← links)
• Effects of HIV infection and ART on phenotype and function of circulating monocytes, natural killer, and innate lymphoid cells. (Q52653716) ‎ (← links)
• Class-modeling analysis reveals T-cell homeostasis disturbances involved in loss of immune control in elite controllers. (Q52680990) ‎ (← links)
• Expression of PD-1 and Tim-3 markers of T-cell exhaustion is associated with CD4 dynamics during the course of untreated and treated HIV infection. (Q54259809) ‎ (← links)
• Polymorphism rs1385129 Within Glut1 Gene SLC2A1 Is Linked to Poor CD4+ T Cell Recovery in Antiretroviral-Treated HIV+ Individuals. (Q55261444) ‎ (← links)
• Genetic variation in CCR2 and CXCL12 genes impacts on CD4 restoration in patients initiating cART with advanced immunesupression (Q64108750) ‎ (← links)
• Lymphopenia-induced proliferation of CD4 T-cells is associated with CD4 T-lymphocyte exhaustion in treated HIV-infected patients (Q89586354) ‎ (← links)
• Assessment of Pattern of CD4+ T-Cell Recovery Among Human Immunodeficiency Virus Patients After Initiation of Highly Active Antiretroviral Therapy at Arsi Negelle Health Center, Ethiopia: A Retrospective Cross-Sectional Study (Q89884221) ‎ (← links)